Searched for
AVANDIA
- Unfair practices: Pharma cos GlaxoSmithkline, Pfizer, Johnson & Johnson and others fined $13 bn in 4 yearsGlaxoSmithkline, Pfizer, Johnson & Johnson, AstraZeneca, Merck, Abbot, Eli Lilly and Allergen have paid about $13 billion in fines to settl...
- After Europe, UAE orders diabetes drug Avandia off shelvesThe UAE's Health Ministry has ordered withdrawal of Avandia, a Type-2 diabetes drug, from all hospitals and pharmacies following a ban in E...
- Glaxo to pull out its diabetes drug from European marketAvandia, manufactured by GlaxoSmithKline, once the world’s best-selling diabetes drug, will be withdrawn from the market in Europe and sale...
- GlaxoSmithKline reports Q2 loss on legal costsGlaxoSmithKline, the world's second-largest pharmaceutical company by revenue, on Wednesday reported a loss of 304 million pounds ($464 mil...
- Experts urge US to restrict drug AvandiaA majority of members of a key advisory committee recommended Wednesday that the US government allow diabetes drug Avandia to stay on the m...
- Glaxo knew of heart risk from Avandia, report saysAvandia came on the market in 1999 and achieved annual revenue of $3 billion by 2006, including sales of a combination drug that includes A...
- Glaxo, Pfizer’s patent claims turned downIndian authorities have rejected the patent applications of GlaxoSmithkline’s anti-diabetic drug Avandia and Pfizer’s cholesterol lowering ...
- GSK diabetes drug to carry risk warningDrug Controller General of India, has asked companies selling diabetes drug rosiglitazone under various brand names to carry a warning on t...
- GlaxoSmithKline to axe 1,000 sales jobs in USThe world's No 2 drugmaker by revenue also will switch from having dual US headquarters to just North Carolina. Shrinking job mkt: The next...
- Glaxo's Viehbacher to leave after missing CEO jobChris Viehbacher, who lost out to Andrew Witty in the race to lead GlaxoSmithKline Plc is to leave the world's second largest drugmaker on ...
- US regulators warn GlaxoSmithKlineFederal regulators have issued a warning to GlaxoSmithKline for not reporting safety results on its diabetes pill Avandia, which received a...
- Diabetes drug may increase chances of osteoporosisThe popular diabetes drug marketed as Avandia may increase bone thinning, a discovery that could help explain why diabetics can have an inc...
- Ranbaxy drug recall seen hitting reputation of Indian generic companiesMore than the commercial effects, industry officials are concerned that the development could have implications on the perception of the qu...
- GlaxoSmithKline to slash costs, jobs as profits dropBritish pharmaceutical giant GlaxoSmithKline said on Wednesday it would cut jobs and costs as it blamed a fall in third-quarter profits on ...
- How Dr Reddy's chased diabetes molecule dreamDr Reddy’s pursuit of past 13 years for the type 2 diabetes molecule is in its last lap, with the product entering the final phase of clini...
- Panel suggests Glaxo's Avandia can stayGlaxoSmithKline's shares surge after a panel of US doctors votes to keep the diabetes pill Avandia on the market.
- Safety scare over Glaxo drug fuels talks of tougher laws in USLaw makers are seizing on last month’s study linking GlaxoSmithKline’s diabetes drug Avandia and heart risks to press for new US drug-safet...
- Glaxo failed to publicise Avandia risksGlaxoSmithKline was the drug industry’s top advertiser last year, promoting its asthma and diabetes treatments to patients and doctors. Inf...
- New study adds to worries about diabetes drug classAnother study has found that diabetes drugs intended to help patients live longer, healthier lives may in fact increase the chances they wi...
- New drug could halt progress of type 2 diabetesDiabetes patients starting out on GlaxoSmithKline’s drug Avandia have a better chance of keeping blood sugar levels within safe limits than...
Load More- GlaxoSmithKline reports Q2 loss on legal costs
